Immunologic Responses in Infants with Asthma and Bronchiolitis.
- Author:
Eun Ho LEE
1
;
Seung Jun KIM
;
Jung Yeon SHIM
;
Hye Lim JUNG
;
Moon Soo PARK
;
Dong Hyuk KEUM
Author Information
1. Department of Pediatrics, School of Medicine, Sungkyunkwan University, Kangbuk Samsung Hospital, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Infantile asthma;
Bronchiolitis;
IL-4;
sICAM-1
- MeSH:
Asthma*;
Bronchiolitis*;
Eosinophils;
Humans;
Infant*;
Intercellular Adhesion Molecule-1;
Interleukin-4;
Respiratory Sounds;
Respiratory Syncytial Viruses
- From:Pediatric Allergy and Respiratory Disease
2002;12(1):18-26
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Respiratory syncytial virus (RSV) is the most common etiologic agent of acute bronchiolitis in infancy, and has been regarded as a possible cause of hyperreactive airway disease later in childhood. This study was performed to compare the immunologic responses between infantile asthma and bronchiolitis and to evaluate whether these immunologic responses can be useful markers to predict the development of subsequent wheezing. METHODS: We analyzed the serum concentrations of interleukin-4 (IL-4) and soluble intercellular adhesion molecule-1 (sICAM-1) from 29 infantile asthmatics, 13 infants with bronchiolitis, and 19 non-atopic controls. RSV infection was confirmed with indirect immunofluorescent staining and viral culture. RESULTS: Serum concentrations of IL-4 and sICAM-1 were significantly higher in infants with asthma compared with infants with those of controls. Peripheral blood eosinophils were significantly decreased in RSV positive bronchiolitis, but there were no differences in the serum concentrations of IL-4 and sICAM-1 between the infants with and without RSV infection. Serum concentrations of IL-4 and sICAM-1 in the first wheezing episode were higher in infants with persistent wheezing than those without. CONCLUSION: There are significant differences in immunologic responses between infantile asthma and bronchiolitis, and the serum IL-4 and sICAM-1 levels in the first wheezing episode may be used as a marker to predict the development of subsequent wheezing.
